Home / Lifestyle / Dancing Star Whitney Leavitt Ditches Ozempic for Macros
Dancing Star Whitney Leavitt Ditches Ozempic for Macros
19 Nov
Summary
- Leavitt stopped taking semaglutide due to negative side effects.
- She previously used WeightWatchers but faced a halt due to hypothyroidism.
- Now, she focuses on counting macros for a healthier food relationship.
Whitney Leavitt, known from MomTok and currently competing on Dancing with the Stars, has been candid about her weight loss experiences. Initially, she found success with WeightWatchers but encountered a plateau attributed to hypothyroidism, a condition affecting her metabolism. This led her to explore other avenues for managing her weight and well-being.
In January 2023, Leavitt revealed she had been taking semaglutide, a GLP-1 medication. While it contributed to a 10 lb loss in one month and helped regulate her blood sugar, she later expressed significant negative side effects. By March 2023, she had stopped the medication after nearly two months, having lost 20 lbs but suffering from persistent nausea and irritability.
Leavitt is now prioritizing a healthier relationship with food. By June 2025, she stated she was no longer using Ozempic and was embracing a new approach: counting macros. This involves meticulously tracking protein, carbohydrates, and fats, a method she finds enjoyable and sustainable for her long-term health goals.
